Clinical Trial Update: TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial TH104 for treating pruritus in primary biliary cholangitis; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• TH104

Snippet

Sponsor: Tharimmune Inc | Conditions: Pruritus, Primary Biliary Cholangitis | Phase 2 | Status: NOT_YET_RECRUITING